Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login

Urology Journal

  • Home
  • Instant Online
    • Instant 2026
    • Instant 2023
    • Instant 2021
    • Instant 2020
  • Current
  • Archives
  • Announcements
  • Submissions
  • Author Guidelines
  • About
    • About the Journal
    • Editorial Team
    • Privacy Statement
    • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 14 No. 1 (2017): January-February2017
  4. CASE REPORT

Vol. 14 No. 1 (2017)

Bahman 2017

Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report

  • Elif Atag
  • Huseyin Salih Semiz
  • Seher Nazli Kazaz
  • Emine Burcin Tuna
  • Ozhan Ozdogan
  • Ozan Bozkurt
  • Omer Demir
  • Aziz Karaoglu

Urology Journal, Vol. 14 No. 1 (2017), 23 Bahman 2017 , Page 2985-2988
https://doi.org/10.22037/uj.v14i1.3697 Published: 2017-01-18

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Penile metastases are extremely rare events and generally occurs at a late stage of primary disease. They mostlyoriginate from prostate and bladder in the genitourinary tract. Penile metastases have a dismal prognosis and verylow survival rates. We report a case of penile metastasis in 70-year-old geriatric male patient with prostatic adenocarcinomawho was treated with cabazitaxel chemotherapy beyond 20 cycles with a good response and acceptableminimal toxicity.

  • PDF

How to Cite

Atag, E., Semiz, H. S., Kazaz, S. N., Tuna, E. B., Ozdogan, O., Bozkurt, O., … Karaoglu, A. (2017). Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report. Urology Journal, 14(1), 2985–2988. https://doi.org/10.22037/uj.v14i1.3697
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 776 times
  • PDF Downloaded: 463 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus